Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells

Nature Immunology

Volumn 6, Issue 7, 2005, Pages 715-721

  Catlett, Ian M ^a   Hedrick, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; SUPPRESSOR OF CYTOKINE SIGNALING 1; T LYMPHOCYTE RECEPTOR; CARRIER PROTEIN; HLA ANTIGEN CLASS 2; HOMEODOMAIN PROTEIN; I E ANTIGEN; I-E-ANTIGEN; RAG 1 PROTEIN; RAG-1 PROTEIN; REPRESSOR PROTEIN; SOCS1 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELL LINEAGE; CYTOLOGY; FLOW CYTOMETRY; GERMFREE ANIMAL; IMMUNOLOGY; MOUSE MUTANT; RADIATION CHIMERA; THYMUS;

ANIMALS; AUTOIMMUNITY; CARRIER PROTEINS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOMEODOMAIN PROTEINS; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RADIATION CHIMERA; REPRESSOR PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; THYMUS GLAND;

EID: 22144464495     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1211     Document Type: Article

References (41)

1. Starr, R. et al. A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921 (1997).
2. Naka, T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929 (1997).
3. Endo, T.A. et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924 (1997).
4. Marine, J.C. et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98, 609-616 (1999).
5. Alexander, W.S. et al. SOCS1 is a critical inhibitor of Interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597-608 (1999).
6. Kubo, M., Hanada, T. & Yoshimura, A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4, 1169-1176 (2003).
7. Naka, T. et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo. Immunity 14, 535-545 (2001).
8. + T cell differentiation. Immunity 18, 475-487 (2003).
9. Lindeman, G.J. et al. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev. 15, 1631-1636 (2001).
10. Kawazoe, Y. et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193, 263-269 (2001).
11. Eyles, J.L., Metcalf, D., Grusby, M.J., Hilton, D.J. & Starr, R. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1. J. Biol. Chem. 277, 43735-43740 (2002).
12. Hanada, T. et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 19, 437-450 (2003).
13. Starr, R. et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395-14399 (1998).
14. -/- mice. Cell 89, 1011-1019 (1997).
15. Peschon, J.J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960 (1994).
16. Moriggl, R. et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10, 249-259 (1999).
17. Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.M. & Berg, L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797 (1995).
18. Cornish, A.L. et al. Suppressor of cytokine signaling-1 has IFN-γ-independent actions in T cell homeostasis. J. Immunol. 170, 878-886 (2003).
19. + T cells. Immunity 13, 59-71 (2000).
20. Scollay, R. & Shortman, K. Thymocyte subpopulations: an experimental review, including flow cytometric cross-correlations between the major murine thymocyte markers. Thymus 5, 245-295 (1983).
21. Berg, L.J. et al. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 58, 1035-1046 (1989).
22. 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342, 435-438 (1989).
23. Kaye, J., Vasquez, N.J. & Hedrick, S.M. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J. Immunol. 148, 3342-3353 (1992).
24. Palmer, E. Negative selection-clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 3, 383-391 (2003).
25. Vasquez, N.J., Kaye, J. & Hedrick, S.M. In vivo and in vitro clonal deletion of double-positive thymocytes. J. Exp. Med. 175, 1307-1316 (1992).
26. Cope, A.P. Exploring the reciprocal relationship between immunity and inflammation in chronic inflammatory arthritis. Rheumatology (Oxford) 42, 716-731 (2003).
27. Rogge, L. et al. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25, 96-101 (2000).
28. Carter, J.D., Neel, B.G. & Lorenz, U. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int. Immunol. 11, 1999-2014(1999).
29. Zhang, J. et al. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J. Immunol. 163, 3012-3021 (1999).
30. + T cells. J. Exp. Med. 197, 475-487 (2003).
31. Hernandez-Hoyos, G., Sohn, S.J., Rothenberg, E.V. & Alberola-Ila, J. Lck activity controls CD4/CD8 T cell lineage commitment. Immunity 12, 313-322 (2000).
32. Itano, A. et al. The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. J. Exp. Med. 183, 731-741 (1996).
33. Veillette, A., Zuniga-Pflucker, J.C., Bolen, J.B. & Kruisbeek, A.M. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J. Exp. Med. 170, 1671-1680 (1989).
34. Legname, G. et al. Inducible expression of a p56 Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity 12, 537-546 (2000).
35. Sharp, L.L. & Hedrick, S.M. Commitment to the CD4 lineage mediated by extracellular signal-related kinase mitogen-activated protein kinase and lck signaling. J. Immunol. 163, 6598-6605 (1999).
36. Matsuda, T., Yamamoto, T., Kishi, H., Yoshimura, A. & Muraguchi, A. SOCS-1 can suppress CD3ζ and Syk-mediated NF-AT activation in a non-lymphoid cell line. FEBS Lett. 472, 235-240 (2000).
37. Baniyash, M. TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4, 675-687 (2004).
38. Cope, A.P. Studies of T-cell activation in chronic inflammation. Arthritis Res. 4 suppl. Suppl 3, S197-S211 (2002).
39. Bronstein-Sitton, N. et al. Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function. Nat. Immunol. 4, 957-964 (2003).
40. Brysha, M. et al. Suppressor of cytokine signaling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo. J. Biol. Chem. 276, 22086-22089 (2001).
41. + T cells in major histocompatibility complex class II-deficient mice. Science 253, 1417-1420 (1991).